Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 157

    1.

    Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat study.

    Pfützner A, Efstrathios K, Löbig M, Armbruster FP, Hanefeld M, Forst T.

    Clin Lab. 2009;55(7-8):275-81.PMID: 19894406 [PubMed - in process]Related articles

    2.

    Reliability of Lightguide Spectrophotometry (O2C) for the Investigation of Skin Tissue Microvascular Blood Flow and Tissue Oxygen Supply in Diabetic and Nondiabetic Subjects.

    Forst T, Hohberg C, Tarakci E, Forst S, Kann P, Pfützner A.

    J Diabetes Sci Technol. 2008 Nov;2(6):1151-6.PMID: 19885305 [PubMed - in process]Free article

    3.

    Resolution of adiponectin oligomers in human plasma using free flow electrophoresis.

    Foucher AL, Hartmann K, Hauptmann M, Wildgruber R, Safinowski M, Forst T, Pfützner A, Gelfand CA, Nissum M.

    Arch Physiol Biochem. 2009 Nov 2. [Epub ahead of print]PMID: 19883214 [PubMed - as supplied by publisher]Related articles

    4.

    Time-Action Profile and Patient Assessment of Inhaled Insulin via the Exubera Device in Comparison with Subcutaneously Injected Insulin Aspart via the FlexPen Device.

    Forst T, Hohberg C, Schöndorf T, Borchert M, Forst S, Roth W, Dehos B, Pfützner A.

    Diabetes Technol Ther. 2009 Feb;11(2):87-92.PMID: 19848574 [PubMed - in process]Related articles

    5.

    Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.

    Meyer S, Schaefer S, Stolk L, Arp P, Uitterlinden AG, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Weise A, Pfützner A, Kann PH.

    Pharmacogenomics. 2009 Oct;10(10):1599-608.PMID: 19842933 [PubMed - in process]Related articles

    6.

    Postprandial Vascular Effects of ViajectTM compared with Insulin Lispro and Regular Human Insulin in Patients with Type 2 Diabetes Mellitus.

    Forst T, Pfützner A, Flacke F, Krasner A, Hohberg C, Tarakci E, Pichotta P, Forst S, Steiner S.

    Diabetes Care. 2009 Oct 6. [Epub ahead of print]PMID: 19808913 [PubMed - as supplied by publisher]Related articles

    7.

    Intensification with prandial insulin.

    Pfützner A, Forst T.

    Int J Clin Pract Suppl. 2009 Oct;(164):11-4.PMID: 19751454 [PubMed - in process]Related articles

    8.

    Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial.

    Jadzinsky M, Pfützner A, Paz-Pacheco E, Xu Z, Allen E, Chen R; CV181-039 Investigators.

    Diabetes Obes Metab. 2009 Jun;11(6):611-22.PMID: 19515181 [PubMed - in process]Related articles

    10.

    Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study.

    Hohberg C, Pfützner A, Forst T, Lübben G, Karagiannis E, Borchert M, Schöndorf T.

    Diabetes Obes Metab. 2009 May;11(5):464-71.PMID: 19422402 [PubMed - in process]Related articles

    11.

    Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter gene.

    Eidens M, Weise A, Prause S, Dahmen N, Wunsch A, Weber MM, Forst T, Pfützner A.

    Mol Diagn Ther. 2009;13(1):25-9. doi: 10.2165/01250444-200913010-00005.PMID: 19351213 [PubMed - indexed for MEDLINE]Related articles

    12.

    FlexPen for the delivery of insulin: accuracy, injection force and patient preference.

    Pfützner A.

    Expert Rev Med Devices. 2009 Mar;6(2):115-23.PMID: 19298158 [PubMed - indexed for MEDLINE]Related articles

    13.

    Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests.

    Safinowski M, Wilhelm B, Reimer T, Weise A, Thomé N, Hänel H, Forst T, Pfützner A.

    Clin Chem Lab Med. 2009;47(4):483-8.PMID: 19284298 [PubMed - indexed for MEDLINE]Related articles

    14.

    Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.

    Pfützner A, Schöndorf T, Hanefeld M, Lübben G, Kann PH, Karagiannis E, Wilhelm B, Forst T.

    Horm Metab Res. 2009 Mar;41(3):202-6. Epub 2009 Feb 17.PMID: 19224430 [PubMed - indexed for MEDLINE]Related articles

    15.

    A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitus.

    Pfützner A, Weber MM, Forst T.

    Clin Lab. 2008;54(11-12):485-90. Review.PMID: 19216254 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.

    Forst T, Hohberg C, Pfützner A.

    Horm Metab Res. 2009 Feb;41(2):123-31. Epub 2009 Feb 12. Review.PMID: 19214922 [PubMed - indexed for MEDLINE]Related articles

    17.

    Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms.

    Meyer S, Schaefer S, Ivan D, Stolk L, Arp P, Uitterlinden AG, Nawroth PP, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Weise A, Pfützner A, Kann PH.

    Pharmacogenomics. 2009 Feb;10(2):293-302.PMID: 19207031 [PubMed - indexed for MEDLINE]Related articles

    19.

    Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.

    Forst T, Wilhelm B, Pfützner A, Fuchs W, Lehmann U, Schaper F, Weber M, Müller J, Konrad T, Hanefeld M.

    Diab Vasc Dis Res. 2008 Nov;5(4):298-303.PMID: 18958840 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease.

    Pfützner A, Marx N, Walcher D, Löbig M, Seidel D, Forst T.

    Clin Lab. 2008;54(7-8):237-41.PMID: 18942491 [PubMed - indexed for MEDLINE]Related articles

    21.

    Elevated peripheral visfatin levels in narcoleptic patients.

    Dahmen N, Manderscheid N, Helfrich J, Musholt PB, Forst T, Pfützner A, Engel A.

    PLoS One. 2008 Aug 20;3(8):e2980.PMID: 18714344 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.

    Pfützner A, Asakura T, Sommavilla B, Lee W.

    Expert Opin Drug Deliv. 2008 Aug;5(8):915-25. Review.PMID: 18713000 [PubMed - indexed for MEDLINE]Related articles

    23.

    Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults.

    Meyer S, Haist M, Schaefer S, Ivan D, Ittner JR, Nawroth PP, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Weise A, Pfützner A, Habbe N, Kann PH.

    Pharmacogenomics. 2008 Aug;9(8):1017-26.PMID: 18681778 [PubMed - indexed for MEDLINE]Related articles

    24.

    Prefilled insulin device with reduced injection force: patient perception and accuracy.

    Pfützner A, Reimer T, Hohberg C, Frøkjaer LP, Jørgensen C.

    Curr Med Res Opin. 2008 Sep;24(9):2545-9. Epub 2008 Jul 31.PMID: 18674410 [PubMed - indexed for MEDLINE]Related articles

    25.

    Role of C-Peptide in the regulation of microvascular blood flow.

    Forst T, Kunt T, Wilhelm B, Weber MM, Pfützner A.

    Exp Diabetes Res. 2008;2008:176245. Review.PMID: 18670621 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    A novel insulin formulation with a more rapid onset of action.

    Steiner S, Hompesch M, Pohl R, Simms P, Flacke F, Mohr T, Pfützner A, Heinemann L.

    Diabetologia. 2008 Sep;51(9):1602-6. Epub 2008 Jul 19.PMID: 18641968 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Intra-Individual Variability of the Metabolic Effect of a Novel Rapid-Acting Insulin (VIAject) in Comparison to Regular Human Insulin.

    Hompesch M, McManus L, Pohl R, Simms P, Pfützner A, Bülow E, Flacke F, Heinemann L, Steiner SS.

    J Diabetes Sci Technol. 2008 Jul;2(4):568-71.PMID: 19885231 [PubMed - in process]Free article

    28.

    Assessment of insulin resistance in young women with polycystic ovary syndrome.

    Jensterle M, Weber M, Pfeifer M, Prezelj J, Pfutzner A, Janez A.

    Int J Gynaecol Obstet. 2008 Aug;102(2):137-40. Epub 2008 May 27.PMID: 18504045 [PubMed - indexed for MEDLINE]Related articles

    29.

    C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.

    Hach T, Forst T, Kunt T, Ekberg K, Pfützner A, Wahren J.

    Exp Diabetes Res. 2008;2008:730594.PMID: 18483566 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions.

    Karagiannis E, Pfützner A, Forst T, Lübben G, Roth W, Grabellus M, Flannery M, Schöndorf T.

    Diabetes Technol Ther. 2008 Jun;10(3):206-12.PMID: 18473695 [PubMed - indexed for MEDLINE]Related articles

    31.

    Differences in the dose accuracy of insulin pens.

    Hänel H, Weise A, Sun W, Pfützner JW, Thomé N, Pfützner A.

    J Diabetes Sci Technol. 2008 May;2(3):478-81.PMID: 19885213 [PubMed - in process]Free article

    32.

    Influence of C-peptide on glucose utilisation.

    Wilhelm B, Kann P, Pfützner A.

    Exp Diabetes Res. 2008;2008:769483.PMID: 18389076 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study.

    Leonhardt W, Pfützner A, Müller J, Pietzsch J, Forst T, Karagiannis E, Lübben G, Hanefeld M.

    Atherosclerosis. 2008 Nov;201(1):155-62. Epub 2008 Apr 18.PMID: 18374336 [PubMed - in process]Related articles

    34.

    Pioglitazone Improves Metabolic Markers in Patients with Type 2 Diabetes Independently from Physical Activities: Results from the IRIS III Study.

    Schöndorf T, Pfützner A, Lübben G, Karagiannis E, Roth W, Forst T.

    J Diabetes Sci Technol. 2008 Mar;2(2):244-9.PMID: 19885350 [PubMed - in process]Free article

    35.

    Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.

    Hohberg C, Forst T, Larbig M, Safinowski M, Diessel S, Hehenwarter S, Weber MM, Schöndorf T, Pfützner A.

    Diabetes Care. 2008 May;31(5):1021-5. Epub 2008 Feb 11.PMID: 18268067 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    The beta-Specific Protein Kinase C Inhibitor Ruboxistaurin (LY333531) Suppresses Glucose-Induced Adhesion of Human Monocytes to Endothelial Cells in Vitro.

    Kunt T, Forst T, Kazda C, Harzer O, Engelbach M, Löbig M, Beyer J, Pfützner A.

    J Diabetes Sci Technol. 2007 Nov;1(6):929-35.PMID: 19885168 [PubMed - in process]Free article

    37.

    Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study.

    Pfützner A, Hanefeld M, Lübben G, Weber MM, Karagiannis E, Köhler C, Hohberg C, Forst T.

    Horm Metab Res. 2007 Oct;39(10):764-8.PMID: 17952841 [PubMed - indexed for MEDLINE]Related articles

    38.

    Review of the pleiotropic effects of peroxisome proliferator-activated receptor gamma agonists on platelet function.

    Borchert M, Schöndorf T, Lübben G, Forst T, Pfützner A.

    Diabetes Technol Ther. 2007 Oct;9(5):410-20. Review.PMID: 17931049 [PubMed - indexed for MEDLINE]Related articles

    39.

    Peripheral leptin levels in narcoleptic patients.

    Dahmen N, Engel A, Helfrich J, Manderscheid N, Löbig M, Forst T, Pfützner A, Tonn P.

    Diabetes Technol Ther. 2007 Aug;9(4):348-53.PMID: 17705690 [PubMed - indexed for MEDLINE]Related articles

    40.

    Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.

    Pfützner A, Weber MM, Forst T.

    Expert Opin Pharmacother. 2007 Aug;8(12):1985-98. Review.PMID: 17696799 [PubMed - indexed for MEDLINE]Related articles

    41.

    Preoperative diagnosis of insulinoma: low body mass index, young age, and female gender are associated with negative imaging by endoscopic ultrasound.

    Kann PH, Ivan D, Pfützner A, Forst T, Langer P, Schaefer S.

    Eur J Endocrinol. 2007 Aug;157(2):209-13.PMID: 17656600 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus.

    Schöndorf T, Lübben G, Hoopmann M, Borchert M, Forst T, Hohberg C, Löbig M, Armbruster FP, Roth W, Grabellus M, Pfützner A.

    Gynecol Endocrinol. 2007 Jun;23(6):356-60.PMID: 17616862 [PubMed - indexed for MEDLINE]Related articles

    43.

    Endothelial Function and Arterial Stiffness in Uncomplicated Type 1 Diabetes and Healthy Controls and the Impact of Insulin on These Parameters during an Euglycemic Clamp.

    Wilhelm B, Weber MM, Kreisselmeier HP, Kugler M, Ries C, Pfützner A, Kann PH, Forst T.

    J Diabetes Sci Technol. 2007 Jul;1(4):582-9.PMID: 19885122 [PubMed - in process]Free article

    44.

    Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.

    Forst T, Karagiannis E, Lübben G, Hohberg C, Schöndorf T, Dikta G, Drexler M, Morcos M, Dänschel W, Borchert M, Pfützner A.

    Atherosclerosis. 2008 Mar;197(1):311-7. Epub 2007 Jun 22.PMID: 17588584 [PubMed - indexed for MEDLINE]Related articles

    45.

    Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.

    Rave K, Heise T, Pfützner A, Boss AH.

    Diabetes Care. 2007 Sep;30(9):2307-8. Epub 2007 Jun 22. No abstract available. PMID: 17586744 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination.

    Pfützner A, Wilhelm B, Forst T.

    Vasc Health Risk Manag. 2007;3(2):211-20. Review.PMID: 17580731 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Development and validation of a new measure to evaluate psychological resistance to insulin treatment.

    Petrak F, Stridde E, Leverkus F, Crispin AA, Forst T, Pfützner A.

    Diabetes Care. 2007 Sep;30(9):2199-204. Epub 2007 Jun 15.PMID: 17575092 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Rotational stability of a single-piece hydrophobic acrylic intraocular lens: new method for high-precision rotation control.

    Weinand F, Jung A, Stein A, Pfützner A, Becker R, Pavlovic S.

    J Cataract Refract Surg. 2007 May;33(5):800-3.PMID: 17466851 [PubMed - indexed for MEDLINE]Related articles

    49.

    Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitus.

    Schöndorf T, Forst T, Hohberg C, Lübben G, Armbruster FP, Roth W, Borchert M, Köder C, Löbig M, Grabellus M, Pfützner A.

    Clin Lab. 2007;53(3-4):193-8.PMID: 17447657 [PubMed - indexed for MEDLINE]Related articles

    50.

    Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain.

    Forst T, Smith T, Schütte K, Marcus P, Pfützner A; CNS 5161 Study Group.

    Br J Clin Pharmacol. 2007 Jul;64(1):75-82. Epub 2007 Mar 28.PMID: 17391323 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...